Picture of Palatin Technologies logo

PTN — Palatin Technologies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Palatin Technologies Inc Reports First Quarter Fiscal Year 2021 Results And Provides Business Update

Nov 17 (Reuters) - Palatin Technologies Inc  PTN.A :
    * PALATIN TECHNOLOGIES, INC. REPORTS FIRST QUARTER FISCAL
YEAR
2021 RESULTS AND PROVIDES BUSINESS UPDATE
    * Q1 LOSS PER SHARE $0.02
    * FROM JULY 25 TO SEPT 30 VYLEESI GROSS SALES $809,100 
    * PHASE 2 CLINICAL RESULTS OF PL9643 FOR TREATMENT OF DRY
EYE
DISEASE ON TRACK FOR DECEMBER 2020
    * ANTICIPATES FILING AN IND & COMMENCING CLINICAL TRIALS
WITH
PL8177 FOR NON-INFECTIOUS UVEITIS, , IN H2 OF CALENDAR YEAR 2021
    * PALATIN TECHNOLOGIES -CONTINUES ITS WORK RELATED TO
TREATMENT OF
PATIENTS WITH DIABETIC RETINOPATHY, WITH IND FILING TARGETED FOR
MID-CALENDAR YEAR 2021
    * PALATIN TECHNOLOGIES- TO POTENTIALLY FILE AN IND WITH FDA,
INITIATE A CLINICAL STUDY OF PL8177 FOR TREATMENT OF COVID-19
PATIENTS EARLY IN Q1 OF 2021

Source text for Eikon:  urn:newsml:reuters.com:*:nL8N2I3493
Further company coverage:  PTN.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Palatin Technologies

See all news